Breaking News Instant updates and real-time market news.

TSM

TSMC

$41.71

0.69 (1.68%)

, SSNLF

Samsung

08:45
01/04/18
01/04
08:45
01/04/18
08:45

TSMC to outpace Samsung in 7nm volume production in 2018, DigiTimes reports

Taiwan Semiconductor Manufacturing Company (TSM) is expected to surpass Samsung Electronics (SSNLF) in 7nm process volume production in 2018, as it has won orders from more than 40 customers, including Apple (AAPL) and Qualcomm (QCOM), DigiTimes reports, citing industry sources. TSMC, which is contracted to produce all the A12 processor chips for the 2018 new-generation iPhone, is implementing extreme ultraviolet technology into its 7nm+ process and ramping up deployments in the 5nm and 3nm processes. Reference Link

TSM

TSMC

$41.71

0.69 (1.68%)

SSNLF

Samsung

AAPL

Apple

$172.23

-0.03 (-0.02%)

QCOM

Qualcomm

$65.94

0.74 (1.14%)

  • 08

    Jan

  • 08

    Jan

TSM TSMC
$41.71

0.69 (1.68%)

12/04/17
SBSH
12/04/17
NO CHANGE
SBSH
Buy
TSMC recent weakness a buying opportunity, says Citi
Citi analyst Roland Shu sees the recent weakness in shares of TSMC as an "enhanced" buying opportunity. The company's "strong" Q4 is on track and Q1 is likely to be better than expected, Shu tells investors in a research note. The analyst has a Buy rating on the shares with a price target of NT$269.
11/27/17
11/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Square (SQ) downgraded to Sell from Neutral at BTIG with analyst Mark Palmer saying he believes the stock's valuation reflects "emphatic and unimpeded growth" but fails to factor in the risks facing the company from increasing competition from First Data's (FDC) Clover, Vantiv (VNTV) and others. 2. Western Digital (WDC) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Katy Huberty saying she believes the NAND industry is entering a downturn for the first time since early 2016. 3. Norfolk Southern (NSC) downgraded to Sell from Hold at Loop Capital with analyst Rick Paterson saying the company's operating efficiency metrics "look like a bit of a disaster at present." 4. TSMC (TSM) and Himax (HIMX) were downgraded to Equal Weight from Overweight at Morgan Stanley. 5. Buffalo Wild Wings (BWLD) downgraded to Neutral from Buy at UBS with analyst Dennis Geiger saying the risk/reward is more balanced following the recent share rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/27/17
MSCO
11/27/17
DOWNGRADE
MSCO
Equal Weight
TSMC, Himax downgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley analyst Charlie Chan downgraded TSMC (TSM) and Himax (HIMX), both to Equal Weight from Overweight, citing a realignment of his investment preferences in the Greater China Semiconductor segment following relative 2017 outperformance compared to the Taiwan Index. While he expects both companies to benefit from long-term trends - in the case of TSMC, HPC demand, and in the case of Himax, Android 3D sensing - he believes that is now reflected in their stock prices.
11/27/17
MSCO
11/27/17
DOWNGRADE
MSCO
Equal Weight
TSMC downgraded to Equal Weight from Overweight at Morgan Stanley
SSNLF Samsung

11/06/17
PIPR
11/06/17
NO CHANGE
Target $68
PIPR
Overweight
Best Buy setup favorable after Apple, Samsung results, says Piper Jaffray
Piper Jaffray analyst Peter Keith sees a favorable setup for Best Buy (BBY) into next week's Q3 results following earnings reports from Apple (AAPL) and Samsung (SSNLF). Both earnings reports are supportive of potential for comp upside for Best Buy over the coming quarters, Keith tells investors in a pre-earnings research note. He reiterates an Overweight rating on the shares with a $68 price target.
11/10/17
COWN
11/10/17
NO CHANGE
Target $195
COWN
Outperform
Universal Display price target raised to $195 from $155 at Cowen
Cowen analyst Robert Stone raised his price target on Universal Display (OLED) to $195 from $155 as he believes the company is poised for a strong 2018. The analyst cited several triggers, including its multi-year deal with Samsung (SSNLF) and the continued ramp of Apple's (AAPL) iPhone X. Stone reiterated his Outperform rating on Universal Display shares.
11/27/17
MSCO
11/27/17
DOWNGRADE
MSCO
Equal Weight
Samsung downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Shawn Kim downgraded Samsung to Equal Weight with a lowered price target of 2.8M won. NAND prices started to reverse in Q4 while visibility on DRAM supply-demand dynamics has reduced beyond Q1 of 2018, Kim tells investors in a research note. He sees downside risk in Samsung with its memory segment not growing materially next year.
12/05/17
FBCO
12/05/17
NO CHANGE
Target $85
FBCO
Outperform
Apple Pay Cash, Samsung Pay not meaningful threats to PayPal, says Credit Suisse
Credit Suisse analyst Paul Condra notes that in addition to Apple (AAPL) rolling out Apple Pay Cash, Samsung (SSNLF) recently filed a patent to introduce a social payment feature to Samsung Pay. While the analyst does not see these as "meaningful threats" to PayPal (PYPL), which has first-mover advantage, he believes the more important takeaway is validation of the social payments model pioneered by Venmo and the expanding ways in which internet companies are integrating payments to bolster the functionality of their platforms. He reiterates an Outperform rating and $85 price target on PayPal's shares.
AAPL Apple
$172.23

-0.03 (-0.02%)

01/02/18
PIPR
01/02/18
NO CHANGE
Target $200
PIPR
Overweight
Piper reiterates $200 target on Apple after iPhone buyer survey
Piper Jaffray analyst Michael Olson says his firm's survey of 400 iPhone buyers increases his confidence that the mix of iPhones sold in fiscal 2018 will be consistent with his expectations. The analyst is modeling iPhone X to account for 38% of iPhones sold this year, essentially in-line with the survey at 35% of buyers intending to buy iPhone X. Olson adds that his estimated mix of iPhone 8 in fiscal 2018 is 40%, directly in-line with the survey. He's "increasingly confident" in his average selling price assumptions and revenue and earnings estimates for Apple in fiscal 2018. Olson reiterates an Overweight rating on the shares with a $200 price target.
01/03/18
PIPR
01/03/18
NO CHANGE
Target $81
PIPR
Overweight
Lumentum is best play on 'surging' 3D sensing market, says Piper Jaffray
Lumentum (LITE) remains the best way to play the "surging" 3D sensing market and the shares are undervaluing the earnings potential from this product segment, Piper Jaffray analyst Troy Jensen tells investors in a research note. Based on conversations with industry contacts, the analyst believes Lumentum captured greater than 90% of initial shipments of VCSELs into Apple's (AAPL) iPhone X. He believes the company will likely capture 75%-90% for the 2018 iPhone launch. Jensen reiterates an Overweight rating on Lumentum with an $81 price target.
01/03/18
CHLM
01/03/18
NO CHANGE
Target $24
CHLM
Buy
ZAGG to benefit from competitor recall, says Craig-Hallum
Craig-Hallum analyst Mike Malouf believes ZAGG (ZAGG) should be an outsized beneficiary of industry-wide screen protector strength this holiday season as competitor Belkin halted sales of its tempered glass screen protectors for Apple's (AAPL) iPhone X after "abysmal customer reviews" reflecting quality issues. Malouf believes ZAGG is set up for another strong year, naming it his top stock pick for 2018. He reiterates a Buy rating and $24 price target on ZAGG shares.
01/03/18
SUSQ
01/03/18
NO CHANGE
SUSQ
Integrated Device wireless charging may be used by Xiaomi, says Susquehanna
Susquehanna analyst Christopher Rolland believes wireless charging adoption will surge as new smartphone makers copy Apple (AAPL). He also thinks Xiaomi may be using Integrated Device's (IDTI) wireless charging in the upcoming flagship Mi7, he tells investors.
QCOM Qualcomm
$65.94

0.74 (1.14%)

12/05/17
NORL
12/05/17
NO CHANGE
Target $18
NORL
Outperform
Himax may see 'fantastic' growth in 2018, says Northland
Northland analyst Tom Sepenzis says Himax (HIMX) could see "fantastic" growth in 2018 if the 3D sensing opportunity plays out the way that management outlined on its last call. While the growth at its large North American customer remains the easiest to quantify, the real opportunity for growth involves the Android handset vendors and the 3D sensing structured light solution developed with Qualcomm (QCOM), he contends. The analyst reiterates an Outperform rating and $18 price target on Himax shares.
12/15/17
OPCO
12/15/17
NO CHANGE
OPCO
Outperform
Broadcom Q2 estimate concerns overblown, says Oppenheimer
After meeting with management, Oppenheimer analyst Rick Schafer believes concerns over the Q2 estimates for Broadcom (AVGO) are overblown. The staggered launches of the two new iPhones creates near-term upside potential, Schafer tells investors in a research note. The company remains his top pick for 2018 with or without Qualcomm (QCOM). He keeps an Outperform rating on the shares with a $315 price target.
12/15/17
JPMS
12/15/17
NO CHANGE
JPMS
JPMorgan sees opportunities in Wireless Semiconductors, prefers Qorvo
JPMorgan analyst Bill Peterson believes the recent pullback in Wireless Semiconductor names, specifically Apple-exposed stocks, creates a good opportunity for investors to take long positions. The analyst sees the most upside in Qorvo (QRVO). He believes fears of production cuts and demand weakness are overblown. The December quarter and outlook for the March quarter are tracking to company expectations that have been built on conservative prospects for smartphone demand, Peterson tells investors in a research note.
12/04/17
KEYB
12/04/17
NO CHANGE
Target $320
KEYB
Overweight
Broadcom price target raised to $320 from $290 at KeyBanc
KeyBanc analyst John Vinh raised his price target for Broadcom (AVGO) to $320 from $290 ahead of quarterly results. The analyst anticipates investor focus will remain on the company's outstanding bid for Qualcomm (QCOM). The analyst believes Broadcom should ultimately be successful in acquiring Qualcomm as he struggles to see how the latter would prevail in a proxy battle. Vinh reiterates an Overweight rating on Broadcom's shares.

TODAY'S FREE FLY STORIES

OPBK

OP Bancorp

05:12
04/23/18
04/23
05:12
04/23/18
05:12
Initiation
OP Bancorp initiated  »

OP Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$58.82

0.18 (0.31%)

05:11
04/23/18
04/23
05:11
04/23/18
05:11
Upgrade
Merck rating change  »

Merck upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 27

    Apr

  • 01

    May

  • 08

    May

  • 05

    Jun

  • 23

    Oct

BDORY

Banco do Brasil

05:04
04/23/18
04/23
05:04
04/23/18
05:04
Downgrade
Banco do Brasil rating change  »

Banco do Brasil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$99.64

-4.57 (-4.39%)

05:02
04/23/18
04/23
05:02
04/23/18
05:02
Upgrade
State Street rating change  »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

KORS

Michael Kors

$65.02

-0.7 (-1.07%)

04:57
04/23/18
04/23
04:57
04/23/18
04:57
Upgrade
Michael Kors rating change  »

Deutsche Bank upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$12.60

-0.47 (-3.60%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    May

AVEO

Aveo Oncology

$2.59

-0.05 (-1.89%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Aveo Oncology management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

CIGI

Colliers International

$70.20

0.75 (1.08%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
UBS REITs analyst to hold an analyst/industry conference call »

REITs Analyst Yulico,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 01

    May

CNAT

Conatus

$3.58

0.02 (0.56%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Conatus management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

KMB

Kimberly-Clark

$100.04

-3.3 (-3.19%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Technical Analysis
Technical Earnings Preview: Kimberly-Clark near 5-year lows ahead of earnings »

The shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 27

    Apr

  • 30

    May

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Existing Home Sales to be reported at 10:00 »

March Existing Home Sales…

INFY

Infosys

$17.38

0.21 (1.22%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Infosys to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

MLNX

Mellanox

$75.80

-1.45 (-1.88%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Mellanox management to meet with Loop Capital »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

APVO

Aptevo Therapeutics

$4.33

0.01 (0.23%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Aptevo Therapeutics management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

April PMI Composite Flash…

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

IFRX

InflaRx

$38.78

1.67 (4.50%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
InflaRx has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts discuss dental…

LUK

Leucadia

$24.02

-0.1 (-0.41%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Leucadia management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    May

  • 04

    Oct

CNK

Cinemark

$39.66

-0.74 (-1.83%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Cinemark management to meet with MKM Partners »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

CRAY

Cray

$22.40

-0.2 (-0.88%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Cray management to meet with Craig Hallum »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 29

    May

SNX

Synnex

$103.51

-0.33 (-0.32%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Synnex management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 03

    May

  • 04

    May

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

March Chicago Fed…

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.